BN Business News
Add your company to Business Communicator →

Business · 11/11/20261 min read

Shanton Pharma Receives EMA and FDA Pediatric Study Waivers for SAP-001 in Hyperuricemia

Summary

Pediatric clinical studies of SAP-001 in hyperuricemia and gout are not needed Significant clinical trial burden and costs avoided due to waiver SINGAPORE and PRINCETON, N.J., Nov.

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →